166 related articles for article (PubMed ID: 23755924)
41. Evaluation of mycosis fungoides management by total skin electron beam therapy with "translational technique".
Gamsiz H; Beyzadeoglu M; Sager O; Dincoglan F; Uysal B; Demiral S; Gundem E; Dirican B
J BUON; 2015; 20(4):1124-31. PubMed ID: 26416066
[TBL] [Abstract][Full Text] [Related]
42. Narrow-band ultraviolet B phototherapy for early stage mycosis fungoides.
Xiao T; Xia LX; Yang ZH; He CD; Gao XH; Chen HD
Eur J Dermatol; 2008; 18(6):660-2. PubMed ID: 18955199
[TBL] [Abstract][Full Text] [Related]
43. Total skin electron beam radiation therapy for mycosis fungoides.
Reddy S; Parker CM; Shidnia H; Gaffney MG; Blyton BD; Pruner LM; Kalasinski LA
Am J Clin Oncol; 1992 Apr; 15(2):119-24. PubMed ID: 1553898
[TBL] [Abstract][Full Text] [Related]
44. Total Skin Electron Beam Therapy with Rotary Dual Technique as Palliative Treatment for Mycosis Fungoides.
Piotrowski T; Fundowicz M; Pawlaczyk M
In Vivo; 2018; 32(3):517-522. PubMed ID: 29695554
[TBL] [Abstract][Full Text] [Related]
45. Narrow-band UVB in the treatment of early stage mycosis fungoides: report of 16 patients.
Ghodsi SZ; Hallaji Z; Balighi K; Safar F; Chams-Davatchi C
Clin Exp Dermatol; 2005 Jul; 30(4):376-8. PubMed ID: 15953074
[TBL] [Abstract][Full Text] [Related]
46. [Mycosis fungoides and radiotherapy. Value of the combination: total skin electron therapy and whole-body photon therapy].
Lambert D; Bousser AM; Dalac S; Godard W; Lepinoy D; Horiot JC
Ann Dermatol Venereol; 1986; 113(6-7):541-7. PubMed ID: 3545028
[TBL] [Abstract][Full Text] [Related]
47. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of dose variation during total skin electron irradiation using thermoluminescent dosimeters.
Weaver RD; Gerbi BJ; Dusenbery KE
Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):475-8. PubMed ID: 7673036
[TBL] [Abstract][Full Text] [Related]
49. Combined modality therapy for tumor stage mycosis fungoides: results of a 10-year follow-up.
Hallahan DE; Griem ML; Griem SF; Medenica M; Soltani K; Lorincz AL; Baron JM
J Clin Oncol; 1988 Jul; 6(7):1177-83. PubMed ID: 3392562
[TBL] [Abstract][Full Text] [Related]
50. Clinical characteristics and long-term outcome of patients with generalized patch and/or plaque (T2) mycosis fungoides.
Kim YH; Chow S; Varghese A; Hoppe RT
Arch Dermatol; 1999 Jan; 135(1):26-32. PubMed ID: 9923777
[TBL] [Abstract][Full Text] [Related]
51. Multiple courses of high-dose total skin electron beam therapy in the management of mycosis fungoides.
Becker M; Hoppe RT; Knox SJ
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1445-9. PubMed ID: 7635786
[TBL] [Abstract][Full Text] [Related]
52. Acute toxicity and risk of infection during total skin electron beam therapy for mycosis fungoides.
Lloyd S; Chen Z; Foss FM; Girardi M; Wilson LD
J Am Acad Dermatol; 2013 Oct; 69(4):537-43. PubMed ID: 23849563
[TBL] [Abstract][Full Text] [Related]
53. Narrowband UVB and PUVA in the treatment of mycosis fungoides: a retrospective study.
Ahmad K; Rogers S; McNicholas PD; Collins P
Acta Derm Venereol; 2007; 87(5):413-7. PubMed ID: 17721648
[TBL] [Abstract][Full Text] [Related]
54. [Total skin irradiation with electrons for mycosis fungoides: criteria for the choice of technique and experimental dosimetry].
Mordacchini C; Antognoni P; Conte L; Novario R; Tordiglione M
Radiol Med; 1990 Oct; 80(4 Suppl 1):143-6. PubMed ID: 2251405
[TBL] [Abstract][Full Text] [Related]
55. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression.
Kim YH; Liu HL; Mraz-Gernhard S; Varghese A; Hoppe RT
Arch Dermatol; 2003 Jul; 139(7):857-66. PubMed ID: 12873880
[TBL] [Abstract][Full Text] [Related]
56. A prospective cohort study of condensed low-dose total skin electron beam therapy for mycosis fungoides: Reduction of disease burden and improvement in quality of life.
Song A; Gochoco A; Zhan T; Sahu J; Alpdogan O; Porcu P; Nikbakht N; Shi W
J Am Acad Dermatol; 2020 Jul; 83(1):78-85. PubMed ID: 32004646
[TBL] [Abstract][Full Text] [Related]
57. Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy.
Perez CA; Grigsby PW; Castro-Vita H; Lockett MA
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1275-88. PubMed ID: 7635767
[TBL] [Abstract][Full Text] [Related]
58. Analysis of long-term outcomes of combined modality therapy for cutaneous T-cell lymphoma.
Duvic M; Apisarnthanarax N; Cohen DS; Smith TL; Ha CS; Kurzrock R
J Am Acad Dermatol; 2003 Jul; 49(1):35-49. PubMed ID: 12833006
[TBL] [Abstract][Full Text] [Related]
59. Total skin electron beam radiotherapy for patients who have mycosis fungoides.
Jones G; Wilson LD; Fox-Goguen L
Hematol Oncol Clin North Am; 2003 Dec; 17(6):1421-34. PubMed ID: 14710893
[TBL] [Abstract][Full Text] [Related]
60. Narrow-band ultraviolet therapy in early-stage mycosis fungoides: study on 20 patients.
Brazzelli V; Antoninetti M; Palazzini S; Prestinari F; Borroni G
Photodermatol Photoimmunol Photomed; 2007 Dec; 23(6):229-33. PubMed ID: 17986058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
